Breathing in a new era: Assessing lung cancer policies in Europe and Asia

This partnership led to an evidence-based, expert-led policy scorecard covering nearly 40 markets in Europe and Asia. By assessing issues such as early diagnosis, patient-centric approaches and timely access to innovations, the work offered detailed insight on how each country could improve care and outcomes for the world’s deadliest cancer.



Contact us
Get in touch
To find our more about how we can work with you